Schonfeld Strategic Advisors’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-81,178
| Closed | -$228K | – | 1880 |
|
|
2023
Q4 | $228K | Sell |
81,178
-67,922
| -46% | -$191K | ﹤0.01% | 1418 |
|
|
2023
Q3 | $428K | Buy |
+149,100
| New | +$428K | ﹤0.01% | 1119 |
|
|
2022
Q4 | – | Sell |
-14,000
| Closed | -$23K | – | 2511 |
|
|
2022
Q3 | $23K | Sell |
14,000
-800
| -5% | -$1.31K | ﹤0.01% | 2637 |
|
|
2022
Q2 | $37K | Sell |
14,800
-5,100
| -26% | -$12.8K | ﹤0.01% | 2179 |
|
|
2022
Q1 | $55K | Buy |
19,900
+5,200
| +35% | +$14.4K | ﹤0.01% | 2262 |
|
|
2021
Q4 | $78K | Sell |
14,700
-200
| -1% | -$1.06K | ﹤0.01% | 1842 |
|
|
2021
Q3 | $126K | Sell |
14,900
-13,600
| -48% | -$115K | ﹤0.01% | 1803 |
|
|
2021
Q2 | $347K | Buy |
+28,500
| New | +$347K | ﹤0.01% | 1339 |
|
|
2021
Q1 | – | Sell |
-33,313
| Closed | -$1.07M | – | 1744 |
|
|
2020
Q4 | $1.07M | Buy |
33,313
+25,213
| +311% | +$808K | 0.01% | 753 |
|
|
2020
Q3 | $244K | Buy |
+8,100
| New | +$244K | ﹤0.01% | 1115 |
|